Intracranial Response of ALK(+) Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

Lung Cancer
11/07/2020

Urbanska EM, et al. Clin Lung Cancer 2020.

NO ABSTRACT